# DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

Study · id `cardio:ct-nct02666742` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02666742](<https://clinicaltrials.gov/study/NCT02666742>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02666742

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 246 participants.

## Technical summary

Registry record NCT02666742. Randomized; no masking; primary purpose prevention. Start 2017-02-16 (actual); primary completion 2020-05-01 (actual). Results posted on 2021-09-24.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 246 participants (enrolled count; ClinicalTrials.gov record NCT02666742, source copy `cardio:ctgov-nct02666742-2022-08-22`, retrieved 2026-10-26)
- Started: 2017-02-16 (actual) (ClinicalTrials.gov record NCT02666742, source copy `cardio:ctgov-nct02666742-2022-08-22`, retrieved 2026-10-26)
- Primary completion: 2020-05-01 (actual) (ClinicalTrials.gov record NCT02666742, source copy `cardio:ctgov-nct02666742-2022-08-22`, retrieved 2026-10-26)
- Completion: 2021-04-30 (actual) (ClinicalTrials.gov record NCT02666742, source copy `cardio:ctgov-nct02666742-2022-08-22`, retrieved 2026-10-26)
- Results first posted: 2021-09-24 (ClinicalTrials.gov record NCT02666742, source copy `cardio:ctgov-nct02666742-2022-08-22`, retrieved 2026-10-26)
- Countries: United States; India (ClinicalTrials.gov record NCT02666742, source copy `cardio:ctgov-nct02666742-2022-08-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02666742-2022-08-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
- Acronym: STROKE-VT
- Condition: Ventricular Tachycardia
- Condition: Premature Ventricular Contraction
- Condition: Stroke
- Intervention (Drug): DOAC
- Intervention (Drug): Aspirin
- Lead sponsor: Kansas City Heart Rhythm Institute
- Lead sponsor class: OTHER
- Collaborator: Kansas City Heart Rhythm Research Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Premature heartbeats (`cardio:premature-heartbeats`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as a collaborator: Kansas City Heart Rhythm Research Foundation (`cardio:org-kansas-city-heart-rhythm-research-foundation`)

## Provenance

Content hash: a8681c03a077c0bd1e9dacf70f5078760333b334c15ec2105288fb23f4f9f3f6
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
